Canadian Pharmacists Journal / Revue des Pharmaciens du Canada http://cph.sagepub.com/
The 2014 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update Sherilyn K. D. Houle, Raj Padwal, Luc Poirier and Ross T. Tsuyuki Canadian Pharmacists Journal / Revue des Pharmaciens du Canada published online 12 May 2014 DOI: 10.1177/1715163514535341 The online version of this article can be found at: http://cph.sagepub.com/content/early/2014/05/12/1715163514535341
Published by: http://www.sagepublications.com
On behalf of:
Canadian Pharmacists Association
Additional services and information for Canadian Pharmacists Journal / Revue des Pharmaciens du Canada can be found at: Email Alerts: http://cph.sagepub.com/cgi/alerts Subscriptions: http://cph.sagepub.com/subscriptions Reprints: http://www.sagepub.com/journalsReprints.nav Permissions: http://www.sagepub.com/journalsPermissions.nav
>> OnlineFirst Version of Record - May 12, 2014 What is This?
Downloaded from cph.sagepub.com at BROWN UNIVERSITY on June 20, 2014
Practice GUIDELINES
Peer-reviewed
The 2014 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update Sherilyn K. D. Houle, BSP, PhD; Raj Padwal, MD, MSc, FRCP(C); Luc Poirier, BPharm, MSc; Ross T. Tsuyuki, BSc(Pharm), PharmD, MSc, FCSHP, FACC
The 2014 Canadian Hypertension Education Program (CHEP) recommendations for the diagnosis and management of hypertension1 represent the 15th annual iteration of these evidence-based guidelines. Since 1999, CHEP and Hypertension Canada have undertaken numerous knowledge translation initiatives to raise awareness and improve the level of hypertension control across the country, and these guidelines represent one key strategy. Pharmacists are a key audience for the CHEP guidelines, as pharmacist care has been conclusively demonstrated to improve outcomes in people with hypertension.2-4 In 2011, we published a complete set of CHEP guidelines specific to the needs of pharmacists5 and an update paper outlining the changes since those guidelines was published in this journal last year.6 The purpose of this article is to highlight the changes made in the 2014 version of the guidelines and their supporting evidence. Therefore, readers are encouraged to interpret this update in conjunction with those previous publications, available on the Canadian Pharmacists Journal website at www.cpjournal.ca, as well as the full guidelines at www.hypertension. ca. Additional information on sodium reduction efforts, health policy considerations and adherence recommendations can be found on the Hypertension Canada website.
Threshold for initiating drug therapy in the very elderly
The 2013 guidelines introduced a specific systolic blood pressure (BP) target, of 160 mmHg were randomized to either placebo or indapamide 1.5 mg daily, with the option of also adding perindopril 2 to 4 mg daily with the goal of attaining a target BP of
The 2014 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update Sherilyn K. D. Houle, Raj Padwal, Luc Poirier and Ross T. Tsuyuki Canadian Pharmacists Journal / Revue des Pharmaciens du Canada published online 12 May 2014 DOI: 10.1177/1715163514535341 The online version of this article can be found at: http://cph.sagepub.com/content/early/2014/05/12/1715163514535341
Published by: http://www.sagepublications.com
On behalf of:
Canadian Pharmacists Association
Additional services and information for Canadian Pharmacists Journal / Revue des Pharmaciens du Canada can be found at: Email Alerts: http://cph.sagepub.com/cgi/alerts Subscriptions: http://cph.sagepub.com/subscriptions Reprints: http://www.sagepub.com/journalsReprints.nav Permissions: http://www.sagepub.com/journalsPermissions.nav
>> OnlineFirst Version of Record - May 12, 2014 What is This?
Downloaded from cph.sagepub.com at BROWN UNIVERSITY on June 20, 2014
Practice GUIDELINES
Peer-reviewed
The 2014 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update Sherilyn K. D. Houle, BSP, PhD; Raj Padwal, MD, MSc, FRCP(C); Luc Poirier, BPharm, MSc; Ross T. Tsuyuki, BSc(Pharm), PharmD, MSc, FCSHP, FACC
The 2014 Canadian Hypertension Education Program (CHEP) recommendations for the diagnosis and management of hypertension1 represent the 15th annual iteration of these evidence-based guidelines. Since 1999, CHEP and Hypertension Canada have undertaken numerous knowledge translation initiatives to raise awareness and improve the level of hypertension control across the country, and these guidelines represent one key strategy. Pharmacists are a key audience for the CHEP guidelines, as pharmacist care has been conclusively demonstrated to improve outcomes in people with hypertension.2-4 In 2011, we published a complete set of CHEP guidelines specific to the needs of pharmacists5 and an update paper outlining the changes since those guidelines was published in this journal last year.6 The purpose of this article is to highlight the changes made in the 2014 version of the guidelines and their supporting evidence. Therefore, readers are encouraged to interpret this update in conjunction with those previous publications, available on the Canadian Pharmacists Journal website at www.cpjournal.ca, as well as the full guidelines at www.hypertension. ca. Additional information on sodium reduction efforts, health policy considerations and adherence recommendations can be found on the Hypertension Canada website.
Threshold for initiating drug therapy in the very elderly
The 2013 guidelines introduced a specific systolic blood pressure (BP) target, of 160 mmHg were randomized to either placebo or indapamide 1.5 mg daily, with the option of also adding perindopril 2 to 4 mg daily with the goal of attaining a target BP of
